Cite Filings / SPRY / 0001193125-24-272445
Feed Companies Filings Check
Sign in
10-Q/A

Filing

ARS Pharmaceuticals, Inc. · Filed 2024-12-06 · Acc 0001193125-24-272445

Documents 1

  • 10-Q/A , d864210d10qa.htm

Around this filing

  • 2024-12-06 144 Sale of Securities
  • 2024-12-06 4 Chief Business Officer sold 144,640 shares at an average $14.11 ($2,041,200)
  • 2024-12-06 10-Q/A 10-Q/A
  • 2024-12-05 144 Sale of Securities
  • 2024-12-04 4 Chief Business Officer sold 90,000 shares at an average $13.43 ($1,208,619)
  • 2024-12-04 4 Director sold 200,000 shares at an average $13.44 ($2,688,751)
  • 2024-12-04 4 Chief Commercial Officer sold 10,000 shares at an average $14.04 ($140,423)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d864210d10qa.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…